Published in Clin Dev Immunol on November 28, 2011
The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. J Autoimmun (2012) 1.01
MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clin Dev Immunol (2013) 0.83
MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro. Autoimmunity (2013) 0.82
Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis. Proteomics Clin Appl (2015) 0.79
Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment. Int Immunopharmacol (2013) 0.78
MicroRNA-let-7a promotes E2F-mediated cell proliferation and NFκB activation in vitro. Cell Mol Immunol (2013) 0.78
Urinary candidate biomarker discovery in a rat unilateral ureteral obstruction model. Sci Rep (2015) 0.78
miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells. Sci Rep (2015) 0.77
Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis. Exp Biol Med (Maywood) (2016) 0.75
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clin Rev Allergy Immunol (2017) 0.75
Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 10.82
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
[Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris) (1968) 4.44
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 2.36
Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A (2008) 2.12
Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int (2007) 2.08
The mesangial cell revisited: no cell is an island. J Am Soc Nephrol (2009) 1.87
Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med (1998) 1.84
Oxidative stress in diabetic nephropathy. Curr Med Chem (2010) 1.70
Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61
The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev (2009) 1.57
Mutational analysis of an autoantibody: differential binding and pathogenicity. J Exp Med (1994) 1.53
Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol (2002) 1.49
Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol (2001) 1.46
Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med (2002) 1.45
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther (2009) 1.44
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med (2001) 1.35
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood (2006) 1.34
Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant (1998) 1.31
Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol (2003) 1.30
Recent findings on genetics of systemic autoimmune diseases. Curr Opin Immunol (2010) 1.19
Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens (2004) 1.17
Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One (2009) 1.14
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum (2006) 1.14
Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol (2006) 1.10
Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J Am Soc Nephrol (2010) 1.09
Nephrotoxic nephritis is mediated by Fcgamma receptors on circulating leukocytes and not intrinsic renal cells. Kidney Int (2002) 1.07
Genetic variation in toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum (2006) 1.05
Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol (2005) 1.04
Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum (2006) 1.03
Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J Am Soc Nephrol (2002) 1.01
Increased glomerular matrix metalloproteinase activity in murine lupus nephritis. Kidney Int (2008) 1.00
Further description of early clinically silent lupus nephritis. Lupus (2006) 0.96
Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant (2008) 0.95
Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J Immunol (2007) 0.95
Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol (2005) 0.94
Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum Pathol (2006) 0.93
Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? Lupus (2000) 0.93
Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum (2009) 0.93
IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. J Rheumatol (2010) 0.93
The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis. Genes Immun (2009) 0.93
Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol (1996) 0.89
Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings. Clin Exp Immunol (2006) 0.89
Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun Rev (2007) 0.88
Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J Rheumatol (2007) 0.86
Glomerular antibodies in lupus nephritis. Clin Rev Allergy Immunol (2011) 0.86
Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int (2006) 0.85
Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus. Clin Exp Med (2006) 0.85
The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus. Ann N Y Acad Sci (2005) 0.85
Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford) (2007) 0.84
The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis. J Autoimmun (2011) 0.83
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol (2006) 0.82
Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol (2006) 0.82
Chromatin as a target antigen in human and murine lupus nephritis. Arthritis Res Ther (2011) 0.82
Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus (2009) 0.82
ISN/RPS 2003 class II mesangial proliferative lupus nephritis: a comparison between cases that progressed to class III or IV and cases that did not. Rheumatol Int (2011) 0.80
Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron (1996) 0.80
Mannose binding lectin gene (MBL2) functional polymorphisms are associated with systemic lupus erythematosus in southern Brazilians. Hum Immunol (2011) 0.79
Qualitative alterations in laminin expression in experimental lupus nephritis. Am J Pathol (1995) 0.79
Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria? Arthritis Rheum (2013) 3.23
Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol (2013) 2.85
BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis Rheum (2007) 2.08
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit (2009) 1.68
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood (2010) 1.66
BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci (2005) 1.64
Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (2006) 1.60
The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. J Autoimmun (2010) 1.49
Diagnostic accuracy of ACR/EULAR 2010 criteria for rheumatoid arthritis in a 2-year cohort. J Rheumatol (2011) 1.47
Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum (2007) 1.43
Changes over time in the diagnosis of rheumatoid arthritis in a 10-year cohort. J Rheumatol (2009) 1.37
Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clin J Am Soc Nephrol (2010) 1.33
What is the contents of the magic draft IVIg? Autoimmun Rev (2008) 1.31
Epigenetics and autoimmunity. J Autoimmun (2010) 1.27
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant (2002) 1.23
Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum (2007) 1.23
Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet (2009) 1.21
Regulatory B cells play a key role in immune system balance. Joint Bone Spine (2012) 1.16
Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol (2008) 1.14
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther (2004) 1.10
IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol (2009) 1.08
Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood (2011) 1.07
Neurological Disorders in Primary Sjögren's Syndrome. Autoimmune Dis (2012) 1.07
The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmun Rev (2009) 1.06
Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods. Ther Drug Monit (2005) 1.04
Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum (2006) 1.03
Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev (2004) 1.03
Human T cells induce their own regulation through activation of B cells. J Autoimmun (2011) 1.03
Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol (2011) 1.02
Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol (2009) 1.02
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil. Clin Pharmacokinet (2005) 1.01
Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol (2003) 1.00
Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med (2011) 1.00
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun (2009) 0.98
Geo-epidemiology and autoimmunity. J Autoimmun (2009) 0.97
Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol (2004) 0.96
Establishment of a novel human B-CLL-like xenograft model in nude mouse. Leuk Res (2005) 0.95
B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev (2010) 0.95
B-cell depletion and repopulation in autoimmune diseases. Clin Rev Allergy Immunol (2008) 0.95
B lymphocytes on the front line of autoimmunity. Autoimmun Rev (2005) 0.95
Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun (2009) 0.94
Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev (2007) 0.94
The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome. Arthritis Rheum (2010) 0.94
Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells. J Autoimmun (2013) 0.94
CD5 expression promotes multiple intracellular signaling pathways in B lymphocyte. Autoimmun Rev (2012) 0.94
Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab. Arthritis Rheum (2010) 0.94
The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun Rev (2007) 0.93
TLR2 is one of the endothelial receptors for beta 2-glycoprotein I. J Immunol (2010) 0.93
Rheumatoid factor on a daily basis. Autoimmunity (2005) 0.92
Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? Arthritis Rheum (2005) 0.92
Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant (2003) 0.92
CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. J Immunol (2011) 0.92
Level of agreement between 2002 American-European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren's syndrome and reasons for discrepancies. Arthritis Res Ther (2014) 0.92
Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum (2005) 0.91
Regulatory B cells in autoimmune diseases: how do they work? Ann N Y Acad Sci (2009) 0.91
Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J Immunol (2008) 0.91
Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. Hum Mutat (2014) 0.91
Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun (2012) 0.91
Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther Drug Monit (2004) 0.90
Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum (2002) 0.90
Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies. Rheumatology (Oxford) (2010) 0.90
Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum (2008) 0.90
B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients. J Immunol (2005) 0.90
Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL. Ann N Y Acad Sci (2007) 0.89
In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev (2011) 0.89
B lymphocytes are required for development and treatment of autoimmune diseases. Ann N Y Acad Sci (2005) 0.89
BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome. Arthritis Rheum (2006) 0.89
BAFF, APRIL, TWE-PRIL: who's who? Autoimmun Rev (2007) 0.89
The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome). Autoimmun Rev (2006) 0.89
IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann N Y Acad Sci (2009) 0.89
Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome. J Autoimmun (2010) 0.89
A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia. Kidney Int (2004) 0.89
A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits. Nephrol Dial Transplant (2010) 0.88
Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun Rev (2007) 0.88
A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients. Br J Clin Pharmacol (2006) 0.88
An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood (2005) 0.88
Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J Immunol (2005) 0.87
Ability of foot radiographs to predict rheumatoid arthritis in patients with early arthritis. J Rheumatol (2004) 0.87
Polarization of B effector cells in Sjögren's syndrome. Autoimmun Rev (2007) 0.87
IL-6 contributes to the expression of RAGs in human mature B cells. J Immunol (2007) 0.87
Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases. Arthritis (2011) 0.87
The antiphospholipid syndrome as a model for B cell-induced autoimmune diseases. Thromb Res (2004) 0.86
TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J Am Soc Nephrol (2009) 0.86
Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev (2002) 0.86
Glomerular antibodies in lupus nephritis. Clin Rev Allergy Immunol (2011) 0.86